Hints and tips:
Related Special Reports
...The three largest charitable foundations focused on public health are to join forces for the first time to tackle climate change’s impact, infectious diseases and measures to improve nutrition and wellbeing...
...Pfizer is “trying to leverage some of that brand equity that they got the world spinning again”, said Markus Saba, a marketing professor at the University of North Carolina Center for the Business of Health...
...Ben Beard, deputy director of the Division of Vector-Borne Diseases at the US Centers for Disease Control and Prevention (CDC), and a co-author of the assessment, says: “We’ve seen a huge increase in tick-borne...
...“The climate crisis has numerous impacts on ecosystems, human health, animal health and food production, which also affect AMR,” according to a report titled “Bracing for Superbugs” published last year by...
...’s UCSF Memory and Aging Center, which played a role in the Leqembi trial....
...The US Centers for Disease Control and Prevention says the risk to public health is low but it is preparing for the possibility that the flu becomes more transmissible between people....
...Investigations needed to happen quickly because the danger could increase as the pathogen evolved, said Michael Osterholm, professor of environmental health sciences at Minnesota university....
...Belkaid is a specialist in the relationship between microbes and the immune system. She was previously director of the US National Institutes of Health Center for Human Immunology....
...A total of 1,319 cases were reported in England during the month of March, the public health body said....
...Unlike rivals Pfizer and BioNTech and Moderna, AstraZeneca initially adopted a non-profit model for its vaccine, selling it “at cost” as part of its agreement with Oxford, and the drug played a key role...
...Properly funded public health interventions are a good example, says Dave Buck, a senior fellow in public health and inequalities at the King’s Fund, a British health think-tank....
...“We’re seeing really incredible improvements that we think are going to unlock a lot of new science,” said John Jumper, DeepMind’s AlphaFold team leader, who cited the potential of the technique to improve...
...Pfeifer said that antibody infusion drugs could be expensive and require infrastructure to deliver regular doses and monitor patients, while vaccines could be administered more cheaply and just two to four...
...Crab, which causes life-threatening illnesses in hospital patients, is classed as a priority concern by the WHO and an urgent threat by the US Centers for Disease Control and Prevention....
...The positive data will also be a boon to Eli Lilly’s efforts to push for more widescale coverage of the drugs by private insurers and US federal health insurance programme Medicare, which were both initially...
...Fake sugar under scrutiny In its filing on soda companies’ use of artificial sweeteners, the Interfaith Center on Corporate Responsibility, a coalition that coordinates investors, cited the World Health...
...Novavax will receive an upfront payment of $500mn in cash and an equity investment, and will stand to receive the remaining $700mn upon the completion of certain regulatory and development milestones....
...“When we talk about links between climate change and human health, the most obvious thing is extreme heat, and extreme weather events,” says Alan Dangour, head of climate and health at the Wellcome Trust...
...Three main focuses would be infectious diseases, health and climate, and mental health....
...AI-driven breakthroughs are occurring in health and biotech every week....
...The first mental health treatment using schedule-1 drug MDMA faces a significant regulatory hurdle as the US Food and Drug Administration is poised to ask outside experts to scrutinise it for post-traumatic...
...Long Covid is exerting a silent drag on work and health, say officials and economists who warn that a struggle to count the costs of the condition is leaving authorities “shooting in the dark”....
...Three-quarters of new or emerging diseases that infect humans originate in animals, according to the US Centers for Disease Control and Prevention....
...Roche, Johnson & Johnson and Denmark’s Genmab have all inked deals this year, following nearly $100bn of ADC-focused M&A and partnership transactions last year....
...health of our furry friends....
International Edition